双甲基酸盐与单甲基酸盐:未解决的药理学问题
Jana Kopincova1, Iveta Bernatova1
1Centre of Experimental Medicine, Slovak Academy of Sciences, Institute of Normal and Pathological Physiology, 813 71 Bratislava, Slovakia.
Pharmaceutics
|December 31, 2025
概括
二甲基烟酸 (DMF) 的代谢是复杂的,关于DMF还是单甲基烟酸 (MMF) 是活性化合物的争论仍在进行中. 关于其药理学的未解决问题使临床应用复杂化.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 生物化学 生化学
背景情况:
- 丁甲基烟酸 (DMF) 已被批准用于多发性硬化症和牛皮,并正在探索其他非恶性疾病.
- 尽管进行了广泛的研究,但DMF的活性代谢物 (DMF或单甲基烟酸,MMF) 和其代谢途径仍然存在争议.
- 关于DMF的作用的体外和体外发现之间存在差异,可能是由于不同的代谢贡献.
研究的目的:
- 审查和强调二甲基烟酸 (DMF) 的代谢和药理学中尚未解决的问题.
- 澄清DMF及其代谢物MMF在观察到的治疗和副作用中的作用.
- 解决将临床前发现转化为临床实践的复杂问题.
主要方法:
- 关于二甲基烟酸 (DMF) 代谢的临床前和临床研究的文献综述.
- 对酶性水解通路的分析,包括基酶.
- 检查DMF和MMF的不同和重叠的影响.
主要成果:
- 确切的部位,范围和负责DMF到MMF的水解的酶尚未完全阐明,并因组织和物种而异.
- 甲醇是DMF代谢的副产品,对观察到的影响,包括NRF2激活的贡献需要进一步调查.
- 区分DMF与MMF在治疗作用和副作用方面的具体作用仍然具有挑战性.
结论:
- 关于DMF代谢和活性代谢物的未解决问题使其临床应用和研究结果的解释复杂化.
- 需要进一步的研究来澄清DMF的精确代谢命运以及DMF,MMF和甲醇对其整体效应的具体贡献.
- 解决这些药理学不确定性对于优化DMF在当前和潜在的未来治疗指示中的使用至关重要.
相关概念视频
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
131
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
131
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
454
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
454
01:29Therapeutic Drug Monitoring: Affecting Factors
170
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
170
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
637
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
637
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
162
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
162
01:24Cholinergic Antagonists: Pharmacokinetics
872
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
872